DexCare’s Regulatory Advantage: Turning Healthcare’s Biggest GTM Obstacle into a Competitive Moat

Regulatory compliance typically sends founders running for the hills. But in a recent episode of Category Visionaries, DexCare CEO Derek Streat revealed a counterintuitive insight that shaped their entire go-to-market strategy: sometimes, the biggest obstacles can become your strongest defenses.

Embracing the Challenge

When Derek transitioned from adtech to healthcare in 2009, conventional wisdom suggested he’d face an uphill battle. Healthcare’s notorious regulatory environment has deterred countless entrepreneurs. Yet DexCare saw something different.

“What I also find is those challenges and headwinds usually can become your competitive differentiators and even the moats that you can build as well because they’re really good at weeding people out of wanting to build businesses in those spaces in the first place,” Derek explains. This insight became central to their strategy.

Building Barriers Through Complexity

Instead of viewing healthcare regulations as limitations, DexCare leveraged them to create barriers to entry. They recognized that the same complexities that make healthcare challenging also protect established players from competition.

Their approach focused on solving problems that “just simply don’t exist” in the current market. By tackling challenges that others avoided, they created unique solutions that were inherently difficult to replicate.

The Providence Advantage

DexCare’s strategy was strengthened by their origins within Providence Health System. “We really have been a product in production inside of this large health system for several years now at this point,” Derek notes. This insider position gave them deep understanding of regulatory requirements and compliance challenges – knowledge that became a competitive advantage.

Strategic Relationships as Moats

To further strengthen their position, DexCare built relationships with industry leaders. “That’s why we have people like Toby Crossgrove on our board who ran Cleveland Clinic, the number two hospital in the entire world. That’s why we have investors like Kaiser Permanente and Providence and Mass General Brigham invested in this organization,” Derek shares.

These relationships didn’t just provide credibility – they created additional regulatory moats. Each partnership deepened their understanding of compliance requirements across different healthcare contexts.

Enterprise-Grade Complexity

DexCare recognized that in healthcare, enterprise sales require a different approach. “We’re a complex solution sale in an enterprise market and one of the most kind of challenging markets out there,” Derek explains. Their response was to focus on thought leadership and strategic relationships rather than traditional sales tactics.

Sustainable Growth Through Regulation

The strategy has proven effective. “We’re either doubling or quadrupling every year across every metric you look at right now in the company,” Derek notes. This growth isn’t despite regulatory challenges – it’s because of how they’ve approached them.

Mapping Real Pain Points

Rather than trying to circumvent regulations, DexCare focused on solving real problems within regulatory constraints. “You can’t necessarily create the pain… you want to expose it and then address it,” Derek emphasizes. This approach ensured their solutions were both compliant and valuable.

Future-Proofing Through Complexity

Looking ahead, DexCare sees their regulatory expertise as key to expansion. “Our vision is that everyone everywhere enjoys exceptional access to the best expertise to treat, prevent and cure illness,” Derek shares. Their deep understanding of healthcare regulations positions them to pursue this vision while maintaining their competitive advantages.

The lesson for founders isn’t to avoid regulated industries – it’s to recognize how regulatory complexity can become a strategic asset. By embracing rather than avoiding regulatory challenges, companies can build sustainable competitive advantages that are difficult for others to replicate.

For B2B tech founders considering regulated markets, DexCare’s story offers a powerful reminder: sometimes the biggest barriers to entry can become your strongest competitive moats – if you’re willing to embrace the complexity and build expertise others won’t.